Skip to content

CAR-T cell therapy research

Most cited papers

  1. Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science · 2003 · 8,242 citations
  2. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaNew England Journal of Medicine · 2017 · 6,172 citations
  3. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic LeukemiaNew England Journal of Medicine · 2018 · 5,900 citations
  4. Chimeric Antigen Receptor T Cells for Sustained Remissions in LeukemiaNew England Journal of Medicine · 2014 · 5,510 citations
  5. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell LymphomaNew England Journal of Medicine · 2018 · 4,230 citations
  6. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicityProceedings of the National Academy of Sciences · 2009 · 3,563 citations
  7. Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine · 1985 · 2,673 citations

Metadata from OpenAlex (CC0).